MJH Life Sciences Expands Reach with RAD Annual Meeting Acquisition
Deal News | Nov 18, 2024 | Globenewswire
MJH Life Sciences has announced the acquisition of the Revolutionizing Atopic Dermatitis (RAD) Annual Meeting, a leading CME-certified conference known for its innovative approach to dermatology education. This strategic acquisition aligns with MJH's mission to advance patient care through superior educational experiences for healthcare professionals. By integrating RAD into its multichannel model, MJH aims to broaden the scope and impact of the meeting across topics such as atopic dermatitis, alopecia areata, vitiligo, and eczema. This move is part of MJH's growth strategy supported by BDT & MSD Partners, LLC, enhancing the company's influence in dermatologic research and education. The RAD conference, chaired by Jonathan I. Silverberg, MD, PhD, MPH, is set to benefit from MJH's expansive media resources, promising unmatched educational offerings to dermatologists worldwide.
Sectors
- Healthcare
- Education
- Media
Geography
- United States – MJH Life Sciences is based in Cranbury, New Jersey, and operates primarily within the U.S., influencing the country's healthcare education landscape.
Industry
- Healthcare – Relevant due to MJH Life Sciences' involvement in healthcare events, media, and educational content.
- Education – The acquisition involves a conference focused on educational programming in the field of dermatology.
- Media – Media resources play a critical role in MJH Life Sciences' strategy to expand the reach and impact of the RAD Annual Meeting.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| MJH Life Sciences | Acquirer | Company | A company focused on healthcare events, media, and education, aimed at improving patient care. |
| Revolutionizing Atopic Dermatitis (RAD) Annual Meeting | Target | Company | A leading CME-certified conference focused on advancing dermatology education. |
| Jonathan I. Silverberg, MD, PhD, MPH | Conference Chair | Person | Chair of the RAD Annual Meeting, under whose leadership the conference collaborates with MJH. |
| BDT & MSD Partners, LLC | Supporter/Investor | Company | Investment firm supporting MJH Life Sciences' growth strategy since 2021. |